| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
4 companies
Schulman Amy W is a Director at Cyclerion Therapeutics, Inc. with holdings across 4 companies. Recent SEC Form 4 filings include 3 buys and 4 sells.
Estimated insider holdings value: $5.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 13, 2025 | GUTS Fractyl Health, Inc. | Director | Buy | 8,550 | $1.17 | $9,964.17 | New | +88.4% | -61.3% | |
| Jun 25, 2024 | ALNY Alnylam Pharmaceuticals, Inc. | Director | Sale+OE | 8,500 | $240.00 | $2,040,000.00 | -50.2% | +13.2% | +34.1% | |
| May 29, 2024 | ALNY Alnylam Pharmaceuticals, Inc. | Director | Sale+OE | 21,700 | $148.60 | $3,224,546.17 | -37.0% | +90.7% | +99.3% | |
| Apr 8, 2019 | CYCN Cyclerion Therapeutics, Inc. | Director | Buy | 626,117 | $16.00 | $10,017,872.00 | New | - | - |